```

[Federal Register Volume 86, Number 125 (Friday, July 2, 2021)]
[Notices]
[Page 35299]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14203]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2021-0034]

Advisory Committee on Immunization Practices (ACIP); Amended 
Notice of Meeting

    Notice is hereby given of a change in the meeting of the Advisory 
Committee on Immunization Practices (ACIP); June 23, 2021, from 10:00 
a.m. to 5:00 p.m., EDT (times subject to change); June 24, 2021, from 
10:30 a.m. to 5:10 p.m., EDT (times subject to change); and June 25, 
2021, from 10:00 a.m. to 12:20 p.m., EDT (times subject to change), in 
the amended FRN. The virtual meeting was published in the Federal 
Register on Wednesday, June 23, 2021, Volume 86, Number 118, pages 
32933-32934.
    The virtual meeting is being amended to update the meeting times on 
June 23-25, 2021 (times subject to change) and matters to be considered 
and should read as follows:
SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), announces the 
following meeting of the Advisory Committee on Immunization Practices 
(ACIP). This meeting is open to the public. Time will be available for 
public comment. The meeting will be webcast live via the World Wide 
Web; for more information on ACIP please visit the ACIP website: http://www.cdc.gov/vaccines/acip/index.html.

DATES: The meeting will be held on June 23, 2021, from 11:00 a.m. to 
4:00 p.m., EDT (times subject to change); June 24, 2021, from 10:00 
a.m. to 5:15 p.m., EDT (times subject to change); and June 25, 2021, 
from 10:00 a.m. to 1:00 p.m., EDT (times subject to change). Written 
comments must be received on or before June 25, 2021.
    A notice of this ACIP meeting has also been posted on CDC's ACIP 
website at: http://www.cdc.gov/vaccines/acip/index.html. In addition, 
CDC has sent notice of this ACIP meeting by email to those who 
subscribe to receive email updates about ACIP.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, Centers for Disease Control and Prevention, 
National Center for Immunization and Respiratory Diseases, 1600 Clifton 
Road NE, MS-H24-8, Atlanta, GA 30329-4027; Telephone: 404-639-8367; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The committee is charged with advising the Director, CDC, 
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, 
the committee is mandated to establish and periodically review and, as 
appropriate, revise the list of vaccines for administration to vaccine-
eligible children through the Vaccines for Children (VFC) program, 
along with schedules regarding dosing interval, dosage, and 
contraindications to administration of vaccines. Further, under 
provisions of the Affordable Care Act, section 2713 of the Public 
Health Service Act, immunization recommendations of the ACIP that have 
been approved by the Director of the Centers for Disease Control and 
Prevention and appear on CDC immunization schedules must be covered by 
applicable health plans.
    Matters To Be Considered: The agenda will include discussions on 
COVID-19, dengue vaccine, herpes zoster vaccines, influenza vaccines, 
pneumococcal vaccine, and rabies vaccine.
    Recommendation votes on dengue vaccine, influenza vaccines and 
rabies vaccine are scheduled. Vaccines for Children (VFC) votes on 
dengue vaccine and influenza vaccines are scheduled. Agenda items are 
subject to change as priorities dictate. For more information on the 
meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-14203 Filed 7-1-21; 8:45 am]
BILLING CODE 4163-18-P
```